<it>LRRK2 </it>in Parkinson's disease – drawing the curtain of penetrance: a commentary
<p>Abstract</p> <p>Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the <it>LRRK2 </it>gene were first described and turned out to be the most frequent...
Main Author: | Krüger Rejko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/6/33 |
Similar Items
-
Pathological Functions of LRRK2 in Parkinson’s Disease
by: Ga Ram Jeong, et al.
Published: (2020-11-01) -
LRRK2 at the Crossroad of Aging and Parkinson’s Disease
by: Eun-Mi Hur, et al.
Published: (2021-03-01) -
The role of LRRK2 in the pathogenesis of Parkinson's disease
by: Petridi, Stavroula
Published: (2017) -
The Gly2019Ser mutation in <it>LRRK2 </it>is not fully penetrant in familial Parkinson's disease: the GenePD study
by: Corbett Alastair, et al.
Published: (2008-11-01) -
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
by: Latourelle, Jeanne, et al.
Published: (2008)